Floatz logo

Sodium Chloride

Oral Mucositis

Vejle HospitalSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Oral Mucositis cohort.

Asset / SponsorPhaseRating
Datopotamab Deruxtecan
AstraZeneca
Phase 4BB
Methylene Blue
Mayo Clinic
Phase 3BB
DEXAMETHASONE
AstraZeneca
Phase 4BB
Palifermin
Swedish Orphan Biovitrum
Phase 3B
MECLOCYCLINE SULFOSALICYLATE
Mucosal Therapeutics
Phase 2B

View all 17 →

Same molecule, other indications

Sodium Chloride is also rated in:

limb ischemiaDormant
BB
Indicative ·
69 / 100
View asset →
Severe Lower Limb IschemiaDormant
BB
Indicative ·
69 / 100
View asset →
mitochondrial diseaseDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →